Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 23, 1999

View Archived Issues

Adolor updates product pipeline at BIO Europe '99

Company Profile: FeRx

Myriad Genetics identifies new HIV drug target

OSI Pharmaceuticals updates oncology programs with Pfizer

Achievements at Genta during third quarter

Novel indolyl derivatives useful for schizophrenia and related disorders

Solid-phase synthesis and use of novel inhibitors of aspartyl proteases reported by Pharmacopeia

U.K. launch of Meningitec coincides with initiation of national immunization program

Dopamine D4 ligands, their preparation and use in schizophrenia and related disorders

CA4P activity reviewed at AACR-NCI-EORTC meeting; Oxigene signs letter of intent with BMS

Tanox patents G-CSF receptor agonists, including MAbs, and their use

Pfizer's portfolio includes new early-stage compounds for MED

NY-ESO-1-derived peptides and their use in cancer therapy and diagnosis

NeXstar presents aptamer against tenascin-C with potential for cancer imaging and therapy

LY-315920 examined for pharmacokinetics following continuous infusion in volunteers

Food reduces rate (but not exent) of absorption of LU-135252/HMR-4005 in man

North American Vaccine to be acquired by Baxter

Novel prostate cancer therapy in development at Procyon detailed at international conference

Preclinical profile of tyrosine kinase inhibitor supports initiation of clinical testing

Pharma Mar isolates marine compound with potent and selective activity against solid tumors

FTY-720: population pharmacokinetics analyzed in transplant patients

Diatide's radiolabeled somatostatin analogue exerts potent antitumor effects in mice

Patent for paclitaxel formulations issued to NaPro BioTherapeutics

Agouron initiates pilot phase II trial of prinomastat as treatment of glioblastoma multiforme

AAPS news: clinical pharmacokinetic analysis of B43-genistein in patients

NeoTherapeutics forms subsidiary to develop drugs discovered through collaboration with UC Irvine

New SERM from SRI and Taiho holds excellent clinical potential

Pharmacokinetics of novel anti-HIV immunoconjugate in nonhuman primates and patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...